Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5835)
All Articles published online
|
Publishing Process of This Article
|
Sep 8, 2015 (publication date) through Apr 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sachdeva M, Chawla YK, Arora SK. Dendritic cells: The warriors upfront-turned defunct in chronic hepatitis C infection. World J Hepatol 2015; 7(19): 2202-2208 [PMID: 26380045 DOI: 10.4254/wjh.v7.i19.2202] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i19/2202.htm |
| Number | Citing Articles |
| 1 |
Jijing Shi, Yuanyuan Li, Wenxian Chang, Xuexiu Zhang, Fu-Sheng Wang. Current progress in host innate and adaptive immunity against hepatitis C virus infection. Hepatology International 2017; 11(4): 374 doi: 10.1007/s12072-017-9805-2
|
| 2 |
Janine Kemming, Robert Thimme, Christoph Neumann-Haefelin. Adaptive Immune Response against Hepatitis C Virus. International Journal of Molecular Sciences 2020; 21(16): 5644 doi: 10.3390/ijms21165644
|
| 3 |
Dina Ragab, Dalia Samaha, Nesrine Mohamed, Mona Rafik, Walid Abdel Hady. Chronic hepatitis C virus infection impairs natural killer cells–dendritic cells cross‐talk: An in vitro culture study. Microbiology and Immunology 2021; 65(2): 76 doi: 10.1111/1348-0421.12858
|
| 4 |
Sabrina Mazouz, Maude Boisvert, Naglaa H Shoukry, Daniel Lamarre. Reversing immune dysfunction and liver damage after direct-acting antiviral treatment for hepatitis C. Canadian Liver Journal 2018; 1(2): 78 doi: 10.3138/canlivj.1.2.007
|
| 5 |
Mohamed M. Nabeel, Rania K. Darwish, Wafaa Alakel, Rabab Maher, Hossam Mostafa, Ahmed Hashem, Mohamed Elbeshlawy, Amr Abul-Fotouh, Hend I. Shousha, Mohamad Saeed Marie. Changes in Serum Interferon Gamma and Interleukin-10 in Relation to Direct-Acting Antiviral Therapy of Chronic Hepatitis C Genotype 4: A Pilot Study. Journal of Clinical and Experimental Hepatology 2022; 12(2): 428 doi: 10.1016/j.jceh.2021.06.018
|
| 6 |
Basma Abdulsamad, Mohamed Afifi, Ashraf K. Awaad, Waleed Elbendary, Hanan Mustafa, Bassem Elsherbini. Effect of Direct Acting Antivirals (DAAs) on Myeloid-Derived Suppressor Cells Population in Egyptian Chronic Hepatitis C Virus Patients: A Potential Immunomodulatory Role of DAAs. Viral Immunology 2023; 36(4): 259 doi: 10.1089/vim.2022.0170
|
| 7 |
Elena Chernykh, Olga Leplina, Ekaterina Oleynik, Marina Tikhonova, Tamara Tyrinova, Natalia Starostina, Alexandr Ostanin. Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial). Immunologic Research 2018; 66(1): 31 doi: 10.1007/s12026-017-8967-2
|
| 8 |
Srikanta Dash, Yucel Aydin, Kyle E Widmer, Leela Nayak. <p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>. Journal of Hepatocellular Carcinoma 2020; : 45 doi: 10.2147/JHC.S221187
|
| 9 |
Sunil K. Arora. Meet the Editorial Board Member. Current HIV Research 2022; 20(3): 199 doi: 10.2174/1570162X2003220913151824
|
| 10 |
E. R. Chernykh, E. A. Oleynik, O. Yu. Leplina, M. A. Tikhonova, T. V. Tyrinova, N. M. Starostina, A. A. Ostanin. Induction of HCV-specific cell response in vitro by dendritic cells generated with interferon-α. Russian Journal of Infection and Immunity 2019; 9(1): 76 doi: 10.15789/2220-7619-2019-1-76-86
|